GO2PHARMACY, INC. 1,000,000 SHARES OF COMMON STOCK UNDERWRITING AGREEMENT ----------------------Underwriting Agreement • September 18th, 2000 • Go2pharmacy Com Inc • Dairy products • New York
Exhibit 10.15 SUBLEASE AND CONSENTSublease Agreement • June 28th, 2002 • Go2pharmacy Com Inc • Dairy products
WITNESSETH:Employment Agreement • December 15th, 1999 • Innovative Health Products Inc • Florida
0 to $24,999 -0- $25,000 to $124,999 $25,000 $125,000 to $224,999 $50,000 $225,000 to $324,999 $75,000 $325,000 to $424,999 $100,000Modification Agreement • June 28th, 2002 • Go2pharmacy Com Inc • Dairy products • Florida
Exhibit 4.4 NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION...Securities Agreement • March 12th, 2004 • Innovative Companies Inc • Pharmaceutical preparations
BY AND AMONGMerger Agreement • June 28th, 2000 • Go2pharmacy Com Inc • Dairy products • Florida
Exhibit 4.2 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this "Agreement") is made and entered into as of March 5, 2004, among Innovative Companies, Inc., a Florida corporation (the "Company"), and the purchasers signatory hereto...Registration Rights Agreement • March 12th, 2004 • Innovative Companies Inc • Pharmaceutical preparations
ARTICLE I DEFINITIONSSecurities Purchase Agreement • March 12th, 2004 • Innovative Companies Inc • Pharmaceutical preparations • New York
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 10th, 2007 • GeoPharma, Inc. • Pharmaceutical preparations • Minnesota
This Securities Purchase Agreement (this “Agreement”) is dated as of April 5, 2007, between GeoPharma, Inc., a Florida corporation (the “Company”), and Whitebox Pharmaceutical Growth Fund, Ltd., a British Virgin Islands business company (including its successors and assigns, the “Purchaser”).
First Community Bank of America SIGNATURES: I AGREE TO THE TERMS OF THIS LINE OF CREDIT. I HAVE RECEIVED A COPY ON TODAY'S DATE. Innovative Health Products, Inc.Line of Credit Agreement • December 15th, 1999 • Innovative Health Products Inc • Florida
EXHIBIT 10.11 CONSULTING AGREEMENT AGREEMENT, dated as of the 27th day of June, 2000, between Go2 Pharmacy.com, Inc., a Florida corporation having an address at 6950 Bryan Dairy Road, Largo, Florida 33777 ("Corporation"), and Joseph Zappala, having an...Consulting Agreement • July 25th, 2000 • Go2pharmacy Com Inc • Dairy products • Florida
EXHIBIT 10.6 EMPLOYMENT AGREEMENT This Employment Agreement (this "Agreement") is made as of June 26, 2000 by Go2Pharmacy.com, Inc., a Florida corporation (the "Employer"), and Carol Dore-Falcone (the "Executive"). Agreement The parties, intending to...Employment Agreement • June 28th, 2000 • Go2pharmacy Com Inc • Dairy products • Florida
AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 30th, 2008 • GeoPharma, Inc. • Pharmaceutical preparations
This Amended and Restated Registration Rights Agreement (this “Agreement”), made and entered into as of April 23, 2008, between GeoPharma, Inc., a Florida corporation (the “Company”), and Whitebox Pharmaceutical Growth Fund, Ltd., a British Virgin Islands business company (including its successors and assigns, the “Holder”), amends and restates the Prior Registration Rights Agreements (as defined below).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • February 13th, 2004 • Innovative Companies Inc • Pharmaceutical preparations • New York
This Agreement is made pursuant to the Securities Purchase Agreement, dated as of the date hereof, by and between the Purchaser and the Company (the “Securities Purchase Agreement”), and pursuant to the Note and the Warrants referred to therein.
UNDERWRITERS'Underwriters' Warrant Agreement • September 18th, 2000 • Go2pharmacy Com Inc • Dairy products • New York
THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS. THIS WARRANT AND THE COMMON STOCK ISSUABLE UPON EXERCISE OF THIS...Warrant Agreement • February 13th, 2004 • Innovative Companies Inc • Pharmaceutical preparations • New York
INNOVATIVE COMPANIES, INC. a corporation organized under the laws of the State of Florida, hereby certifies that, for value received, LAURUS MASTER FUND, LTD., or assigns (the “Holder”), is entitled, subject to the terms set forth below, to purchase from the Company (as defined herein) from and after the Issue Date of this Warrant and at any time or from time to time before 5:00 p.m., New York time, through the close of business February 10, 2011 (the “Expiration Date”), up to 150,000 fully paid and nonassessable shares of Common Stock (as hereinafter defined), $0.01 par value per share, at the applicable Exercise Price per share (as defined below). The number and character of such shares of Common Stock and the applicable Exercise Price per share are subject to adjustment as provided herein.
EXHIBIT 10.5 EMPLOYMENT AGREEMENT This Employment Agreement (this "Agreement") is made as of June 26, 2000 by Go2Pharmacy.com, Inc., a Florida corporation (the "Employer"), and Mihir K. Taneja (the "Executive"). Agreement The parties, intending to be...Employment Agreement • June 28th, 2000 • Go2pharmacy Com Inc • Dairy products • Florida
EXHIBIT 4.3 ADVISORY AND INVESTMENT BANKING AGREEMENT This Agreement is made and entered into as of the [__]th day of [____], 2000 by and between Utendahl Capital Partners, L.P., a New York Limited Partnership ("Utendahl") and Go2Pharmacy, Inc., a...Advisory and Investment Banking Agreement • September 18th, 2000 • Go2pharmacy Com Inc • Dairy products • New York
EMPLOYMENT AGREEMENTEmployment Agreement • June 30th, 2008 • GeoPharma, Inc. • Pharmaceutical preparations • Florida
This Employment Agreement (the “Agreement”) is made and entered into effective as of the 1st day of April, 2008, by and between GEOPHARMA, INC., a Florida corporation (the “Company”), and MANDEEP K. TANEJA, an individual (“Executive”).
INNOVATIVE COMPANIES, INC. SECURITIES PURCHASE AGREEMENT January , 2004Securities Purchase Agreement • February 13th, 2004 • Innovative Companies Inc • Pharmaceutical preparations • New York
THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of January , 2004, by and between INNOVATIVE COMPANIES, INC., a Minnesota corporation (the “Company”), and Laurus Master Fund, Ltd., a Cayman Islands company (the “Purchaser”).
SECURITIES EXCHANGE AGREEMENTSecurities Exchange Agreement • August 6th, 2010 • GeoPharma, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of August 2, 2010, between GeoPharma, Inc., a Florida corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
EXHIBIT 10.9 GO2Pharmacy.com Agreement This Ancillary Services Agreement (the "Agreement") is entered into as of March 23, 2000 between CarePlus, LLC d/b/a CarePlus Health Plan, ("CarePlus Health Plan"), a limited liability company certified as a...Ancillary Services Agreement • June 28th, 2000 • Go2pharmacy Com Inc • Dairy products • New York
ContractSecured Convertible Term Note • February 13th, 2004 • Innovative Companies Inc • Pharmaceutical preparations • New York
THIS NOTE AND THE COMMON SHARES ISSUABLE UPON CONVERSION OF THIS NOTE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS. THIS NOTE AND THE COMMON SHARES ISSUABLE UPON CONVERSION OF THIS NOTE MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO THIS NOTE UNDER SAID ACT AND ANY APPLICABLE STATE SECURITIES LAWS OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO INNOVATIVE COMPANIES, INC. THAT SUCH REGISTRATION IS NOT REQUIRED.
ContractConvertible Security Agreement • October 21st, 2009 • GeoPharma, Inc. • Pharmaceutical preparations • Minnesota
NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THIS SECURITY AND THE SECURITIES ISSUABLE UPON CONVERSION OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.
GEOPHARMA, INC. SECURED CONVERTIBLE NOTE PURCHASE AGREEMENT April 5, 2007Secured Convertible Note Purchase Agreement • April 10th, 2007 • GeoPharma, Inc. • Pharmaceutical preparations • Minnesota
Exhibit 10.17 PROMISSORY NOTE ------------------------------------------------- ------------------------------- Principal Loan Date Maturity Loan No Call / Coll Account $900,000.00 03-01-2003 29962 -------------------------------------...Promissory Note • June 30th, 2003 • Innovative Cos Inc • Dairy products • Florida
STOCK PLEDGE AGREEMENTStock Pledge Agreement • February 13th, 2004 • Innovative Companies Inc • Pharmaceutical preparations • New York
This Stock Pledge Agreement (this “Agreement”) dated as of January 30, 2004, between Laurus Master Fund, Ltd. (“Pledgee”), and Innovative Companies, Inc. (“Pledgor”).
WARRANT TO PURCHASE COMMON STOCK OF GEOPHARMA, INC. VOID AFTER APRIL 5, 2014Warrant Agreement • April 10th, 2007 • GeoPharma, Inc. • Pharmaceutical preparations
THIS WARRANT (the “Warrant”) is issued to Whitebox Pharmaceutical Growth Fund, Ltd. or its registered assigns (the “Holder”) by GeoPharma, Inc., a Florida corporation (the “Company”), on April 5, 2007 (the “Initial Exercise Date”). This Warrant is issued in connection with the Company’s issuance to the Holder of 400,000 shares (the “Shares”) of the Company’s common stock, $.01 par value (the “Common Stock”) pursuant to the terms of that certain Securities Purchase Agreement, dated as of April 5, 2007 (the “Purchase Agreement”). This Warrant is intended to be an investment warrant and is purchased together with the Shares issued pursuant to the Purchase Agreement and is not issued in consideration of any services.
EXHIBIT 10.7 COMMERCIAL LEASE 1. PARTIES. This Lease is made this 1st day of October, 1999, by and between DYNAMIC HEALTH PRODUCTS, INC., a Florida corporation (herein called "Landlord") and INNOVATIVE HEALTH PRODUCTS, INC., a Florida corporation...Commercial Lease • October 19th, 2000 • Go2pharmacy Com Inc • Dairy products • Florida
SECURITY AGREEMENTSecurity Agreement • June 30th, 2008 • GeoPharma, Inc. • Pharmaceutical preparations
Commercial ContractPurchase and Sale Agreement • October 29th, 2004 • GeoPharma, Inc. • Pharmaceutical preparations • Florida
AGREEMENT AND PLAN OF REORGANIZATION BY AND AMONG GEOPHARMA, INC. FLORIDA MERGER SUBSIDIARY CORP. AND DYNAMIC HEALTH PRODUCTS, INC. Dated May 14, 2007Agreement and Plan of Reorganization • May 17th, 2007 • GeoPharma, Inc. • Pharmaceutical preparations • Florida
This AGREEMENT AND PLAN OF REORGANIZATION (this “Agreement”) is made and entered into as of May 14, 2007, by and among GeoPharma, Inc., a Florida corporation (“Parent”), Florida Merger Subsidiary Corp., a Florida corporation and a wholly-owned subsidiary of Parent (“DYHP Acquisition”), and Dynamic Health Products, Inc., a Florida corporation (the “Company”).
ASSET AND STOCK PURCHASE AGREEMENTAsset and Stock Purchase Agreement • August 6th, 2010 • GeoPharma, Inc. • Pharmaceutical preparations
THIS ASSET AND STOCK PURCHASE AGREEMENT is made and entered into as of August 2, 2010 by and among Belcher Pharmaceuticals, Inc., a Florida corporation (“Seller”), GeoPharma, Inc., a Florida corporation (“GeoPharma”), and Belcher Pharmaceuticals Acquisition, LLC, a Florida limited liability company (“Buyer”).
SUBSIDIARY GUARANTYSubsidiary Guaranty • February 13th, 2004 • Innovative Companies Inc • Pharmaceutical preparations • New York
FOR VALUE RECEIVED, and in consideration of note and securities purchases from, loans made or to be made or credit otherwise extended or to be extended by Laurus Master Fund, Ltd. (“Laurus”) to or for the account of Innovative Companies, Inc. and Innovative Companies Inc. Subsidiary ( collectively, “Debtor”) from time to time and at any time and for other good and valuable consideration and to induce Laurus, in its discretion, to purchase such notes, make such loans or extensions of credit and to make or grant such renewals, extensions, releases of collateral or relinquishments of legal rights as Laurus may deem advisable, each of the undersigned (and each of them if more than one, the liability under this Guaranty being joint and several) (jointly and severally referred to as “Guarantors “ or “the undersigned”) unconditionally guaranties to Laurus, its successors, endorsees and assigns the prompt payment when due (whether by acceleration or otherwise) of all present and future obligat
SECOND AMENDED AND RESTATED SECURED CONVERTIBLE NOTE PURCHASE AGREEMENT October 15, 2009Secured Convertible Note Purchase Agreement • October 21st, 2009 • GeoPharma, Inc. • Pharmaceutical preparations • Minnesota
